InsidersTradesSigma
Follow the 삼성에피스홀딩스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼성에피스홀딩스 has published 12 insider filings. Market capitalisation: €8,659.3bn. The latest transaction was disclosed on 1 April 2026 (Sale). Among the most active insiders: 삼성에피스홀딩스. Every trade is accessible without an account.
Analysts rate 삼성에피스홀딩스 Buy (bullish), based on 2 analysts. Average price target: ₩600,000.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
Samsung Epise Holdings 是一家在 XKRX 市场上市的医疗保健和制药公司。该公司专注于创新医药产品的开发和商业化。